LifeSci Capital analyst Sam Slutsky has maintained their bullish stance on ORKA stock, giving a Buy rating today. Sam Slutsky’s rating is based on Oruka Therapeutics’ strong financial position and ...

Wedbush analyst David Nierengarten maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) today and set a price target of ...

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical ...

Achieve streamlined DevOps and IT processes with your existing Mac compute – on prem or in the cloud – with Orka Engine’s ...

Opinions expressed by Forbes Contributors are their own. Steven covers accessibility and assistive technologies. In all my briefings with Apple on AirPods over the years, one of the first things ...

Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) is one of 39 public companies in the “Diagnostic substances” industry, but how does it weigh in compared to its peers? We will compare Oruka ...

Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have earned a consensus rating of “Buy” from the eight ...

The American Film Festival has announced the nine winners of the US in Progress Wrocław industry program, and they include [… ...

MacStadium, a leader in macOS virtualization and cloud services, has just announced Orka Engine, the latest addition to its Orka lineup. Unveiled today as part of KubeCon, this product is designed to ...